Skip to main content

Advertisement

SpringerLink
Log in

Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson’s disease patients

  • Neurology and Preclinical Neurological Studies - Original Article
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

A Correction to this article was published on 04 September 2023

This article has been updated

Abstract

Background

This study aimed at assessing the cross-sectional and longitudinal clinimetrics and feasibility of the Frontal Assessment Battery (FAB) in non-demented Parkinson’s disease (PD) patients.

Methods

N = 109 PD patients underwent the FAB and the Montreal Cognitive Assessment (MoCA). A subsample of patients further underwent a thorough motor, functional and behavioral evaluation (the last including measures of anxiety, depression and apathy). A further subsample was administered a second-level cognitive battery tapping on attention, executive functioning, language, memory, praxis and visuo-spatial abilities. The following properties of the FAB were tested: (1) concurrent validity and diagnostics against the MoCA; (2) convergent validity against the second-level cognitive battery; (4) association with motor, functional and behavioral measures; (5) capability to discriminate patients from healthy controls (HCs; N = 96); (6) assessing its test–retest reliability, susceptibility to practice effects and predictive validity against the MoCA, as well as deriving reliable change indices (RCIs) for it, at a ≈ 6-month interval, within a subsample of patients (N = 33).

Results

The FAB predicted MoCA scores at both T0 and T1, converged with the vast majority of second-level cognitive measures and was associated with functional independence and apathy. It accurately identified cognitive impairment (i.e., a below-cut-off MoCA score) in patients, also discriminating patients from HCs. The FAB was reliable at retest and free of practice effects; RCIs were derived according to a standardized regression-based approach.

Discussion

The FAB is a clinimetrically sound and feasible screener for detecting dysexecutive-based cognitive impairment in non-demented PD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data availability

Datasets associated with the present study are available upon reasonable request of interested researchers at the following link: https://zenodo.org/record/7774009#.ZCFpDnZBxPZ.

Change history

References

  • Aiello EN, Rimoldi S, Bolognini N, Appollonio I, Arcara G (2022a) Psychometrics and diagnostics of Italian cognitive screening tests: a systematic review. Neurol Sci 43:821–845

    Article  PubMed  Google Scholar 

  • Aiello EN, Gramegna C, Esposito A, Gazzaniga V, Zago S, Difonzo T, Bolognini N (2022b) The montreal cognitive assessment (MoCA): updated norms and psychometric insights into adaptive testing from healthy individuals in Northern Italy. Aging Clin Exp Res 34: 375–382.

  • Aiello EN, Esposito A, Appollonio I, Bolognini N (2022c) Diagnostic properties of the Frontal Assessment Battery (FAB) in Italian healthy adults. Aging Clin Exp Res 34:1021–1026

    Article  PubMed  Google Scholar 

  • Amboni M, Cozzolino A, Longo K, Picillo M, Barone P (2008) Freezing of gait and executive functions in patients with Parkinson’s disease. Mov Disord 23:395–400

    Article  PubMed  Google Scholar 

  • American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (5th ed.)

  • Appollonio I, Leone M, Isella V, Piamarta F, Consoli T, Villa ML, Nichelli P (2005) The frontal assessment battery (FAB): normative values in an Italian population sample. Neurol Sci 26:108–116

    Article  CAS  PubMed  Google Scholar 

  • Barbarotto R, Laiacona M, Frosio R, Vecchio M, Farinato A, Capitani E (1998) A normative study on visual reaction times and two Stroop colour-word tests. Italian J Neurol Sci 19:161–170

    Article  CAS  Google Scholar 

  • Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571

    Article  CAS  PubMed  Google Scholar 

  • Benton AL, Varney NR, Hamsher KD (1978) Visuospatial judgment: a clinical test. Arch Neurol 35:364–367

    Article  CAS  PubMed  Google Scholar 

  • Biundo R, Weis L, Facchini S, Formento-Dojot P, Vallelunga A, Pilleri M, Antonini A (2014) Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia. Parkinsonism Relat Disord 20:394–399

    Article  PubMed  Google Scholar 

  • Biundo R, Weis L, Pilleri M, Facchini S, Formento-Dojot P, Vallelunga A, Antonini A (2013) Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson’s disease. J Neural Transm 120:627–633

    Article  PubMed  Google Scholar 

  • Cahn DA, Sullivan EV, Shear PK, Pfefferbaum A, Heit G, Silverberg G (1998) Differential contributions of cognitive and motor component processes to physical and instrumental activities of daily living in Parkinson’s disease. Arch Clin Neuropsychol 13:575–583

    CAS  PubMed  Google Scholar 

  • Caltagirone C, Gainotti G, Masullo C, Miceli G (1979) Validity of some neuropsychological tests in the assessment of mental deterioration. Acta Psychiatr Scand 60:50–56

    Article  CAS  PubMed  Google Scholar 

  • Capasso R, Miceli G (2001) Esame Neuropsicologico per l'Afasia: ENPA . Springer Science & Business Media

  • Carlesimo GA, Caltagirone C, Gainotti G (1996) The mental deterioration battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. Eur Neurol 36:378–384

    Article  CAS  PubMed  Google Scholar 

  • Chou KL, Amick MM, Brandt J, Camicioli R, Frei K, Gitelman D (2010) A recommended scale for cognitive screening in clinical trials of Parkinson’s disease. Movem Disord 25:2501–2507

    Article  Google Scholar 

  • Chung SJ, Yoo HS, Lee HS, Lee YH, Baik K, Jung JH, Lee PH (2021) Baseline cognitive profile is closely associated with long-term motor prognosis in newly diagnosed Parkinson’s disease. J Neurol 268:4203–4212

    Article  CAS  PubMed  Google Scholar 

  • Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55:1621–1626

    Article  CAS  PubMed  Google Scholar 

  • Duff K (2012) Evidence-based indicators of neuropsychological change in the individual patient: relevant concepts and methods. Arch Clin Neuropsychol 27:248–261

    Article  PubMed  PubMed Central  Google Scholar 

  • D’Iorio A, Maggi G, Vitale C, Trojano L, Santangelo G (2018) “Pure apathy” and cognitive dysfunctions in Parkinson’s disease: a meta-analytic study. Neurosci Biobehav Rev 94:1–10

    Article  PubMed  Google Scholar 

  • Fahn S, Elton RL, UPDRS program members (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB (Eds) Recent developments in Parkinson’s disease, pp. 153–163

  • Federico A, Trentin M, Zanette G, Mapelli D, Picelli A, Smania N, Tamburin S (2017) Diagnosing mild cognitive impairment in Parkinson’s disease: which tests perform best in the Italian population? Neurol Sci 38:1461–1468

    Article  PubMed  Google Scholar 

  • Gasca‐Salas, C., Duff‐Canning, S., Armstrong, M. J., Eslinger, P. J., Schneider, R. B., Kennedy, N., ... & Marras, C. (2020). Parkinson disease with mild cognitive impairment: Domain‐specific cognitive complaints predict dementia. Acta Neurologica Scandinavica, 142, 585–596.

  • Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E (1996) Trail making test: normative values from 287 normal adult controls. Neurol Sci 17:305–309

    CAS  Google Scholar 

  • Hurtado-Pomares M, Carmen Terol-Cantero M, Sánchez-Pérez A, Peral-Gómez P, Valera-Gran D, Navarrete-Muñoz EM (2018) The frontal assessment battery in clinical practice: a systematic review. Int J Geriatr Psychiatry 33:237–251

    Article  PubMed  Google Scholar 

  • Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Parkinson Study Group (1990) Variable expression of Parkinson’s disease: a base-line analysis of the DAT ATOP cohort. Neurology 40:1529–1529

    Article  CAS  PubMed  Google Scholar 

  • Kataoka H, Tanaka N, Saeki K, Kiriyama T, Ueno S (2014) Low frontal assessment battery score as a risk factor for falling in patients with Hoehn-Yahr Stage III Parkinson’s disease: a 2-year prospective study. Eur Neurol 71:187–192

    Article  PubMed  Google Scholar 

  • Kim HY (2013) Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod 38:52–54

    Article  PubMed  PubMed Central  Google Scholar 

  • Kudlicka A, Clare L, Hindle JV (2011) Executive functions in Parkinson’s disease: systematic review and meta-analysis. Mov Disord 26:2305–2315

    Article  PubMed  Google Scholar 

  • Kulisevsky J, Pagonabarraga J (2009) Cognitive impairment in Parkinson’s disease: tools for diagnosis and assessment. Mov Disord 24:1103–1110

    Article  PubMed  Google Scholar 

  • Larner AJ (2019) New unitary metrics for dementia test accuracy studies. Prog Neurol Psychiatry 23:21–25

    Article  Google Scholar 

  • Larner AJ (2021b). Paired measures. In: Larner AJ (ed) The 2x2 Matrix. Contingency, Confusion, and the Metrics of Binary Classification, pp. 15–48

  • Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: movement disorder society task force guidelines. Movem Disord 27:349–356

    Article  Google Scholar 

  • Litvan I, Kieburtz K, Tröster AI, Aarsland D (2018) Strengths and challenges in conducting clinical trials in Parkinson’s disease mild cognitive impairment. Mov Disord 33:520–527

    Article  PubMed  Google Scholar 

  • Marconi R, Antonini A, Barone P, Colosimo C, Avarello TP, Bottacchi E, Morgante L (2012) Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders. Neurol Sci 33:585–593

    Article  PubMed  Google Scholar 

  • Monaco M, Costa A, Caltagirone C, Carlesimo GA (2013) Forward and backward span for verbal and visuo-spatial data: standardization and normative data from an Italian adult population. Neurol Sci 34:749–754

    Article  PubMed  Google Scholar 

  • Novelli G, Papagno C, Capitani E, Laiacona M, Cappa SF, Vallar G (1986) Tre test clinici di ricerca e produzione lessicale. Taratura su sogetti normali. Arch Psicol Neurol Psichiatr 47:278–296

    Google Scholar 

  • Paulwoods S, Tröster AI (2003) Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson’s disease. J Int Neuropsychol Soc 9:17–24

    Article  Google Scholar 

  • Petkus AJ, Filoteo JV, Schiehser DM, Gomez ME, Hui JS, Jarrahi B, Petzinger GM (2020) Mild cognitive impairment, psychiatric symptoms, and executive functioning in patients with Parkinson’s disease. Int J Geriat Psychiatry 35:396–404

    Article  Google Scholar 

  • Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Deuschl, G (2015) MDS clinical diagnostic criteria for Parkinson's disease. Movem Disord 30: 1591–1601.

  • Puente AN, Cohen ML, Aita S, Brandt J (2016) Behavioral ratings of executive functioning explain instrumental activities of daily living beyond test scores in Parkinson’s disease. Clin Neuropsychol 30:95–106

    Article  PubMed  Google Scholar 

  • Rodriguez-Oroz MC, Jahanshahi M, Krack P, Litvan I, Macias R, Bezard E, Obeso JA (2009) Initial clinical manifestations of Parkinson’s disease: features and pathophysiological mechanisms. Lancet Neurol 8:1128–1139

    Article  CAS  PubMed  Google Scholar 

  • Santangelo G, Raimo S, Siciliano M, D’Iorio A, Piscopo F, Cuoco S, Trojano L (2017) Assessment of apathy independent of physical disability: validation of the Dimensional Apathy Scale in Italian healthy sample. Neurol Sci 38:303–309

    Article  PubMed  Google Scholar 

  • Schwab RS, England AC (1969) Projection technique for evaluating surgery in Parkinson’s disease. In: Gillingham FJ, Donaldson MC (eds) Third Symposium on Parkinson’s Disease, pp. 152–157

  • Skorvanek M, Goldman JG, Jahanshahi M, Marras C, Rektorova I, Schmand B, Violante MR (2018) Global scales for cognitive screening in Parkinson’s disease: critique and recommendations. Movem Disord 33:208–218

    Article  Google Scholar 

  • Smulders K, van Nimwegen M, Munneke M, Bloem BR, Kessels RP, Esselink RA (2013) Involvement of specific executive functions in mobility in Parkinson’s disease. Parkinsonism Relat Disord 19:126–128

    Article  PubMed  Google Scholar 

  • Solca F, Aiello EN, Migliore S, Torre S, Carelli L, Ferrucci R, Poletti B (2022) Diagnostic properties of the frontal assessment battery (FAB) in Huntington’s disease. Front Psychol 13:1031871

    Article  PubMed  PubMed Central  Google Scholar 

  • Spielberger CD, Gonzalez-Reigosa F, Martinez-Urrutia A, Natalicio LF, Natalicio DS (1971) The state-trait anxiety inventory. Interam J Psychol 5:145–158

    Google Scholar 

  • Spinnler H, Tognoni G (1987) Standardizzazione e taratura italiana di una batteria di test neuropsicologici. Neurol Sci 6:S1–S120

    Google Scholar 

  • Varalta V, Picelli A, Fonte C, Amato S, Melotti C, Zatezalo V, Smania N (2015) Relationship between cognitive performance and motor dysfunction in patients with Parkinson’s disease: a pilot cross-sectional study. BioMed Res Int 2015:365959

    Article  PubMed  PubMed Central  Google Scholar 

  • Varanese S, Perfetti B, Ghilardi MF, Di Rocco A (2011) Apathy, but not depression, reflects inefficient cognitive strategies in Parkinson’s disease. PLoS ONE 6:e17846

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vlagsma TT, Koerts J, Tucha O, Dijkstra HT, Duits AA, van Laar T, Spikman JM (2017) Objective versus subjective measures of executive functions: predictors of participation and quality of life in Parkinson disease? Arch Phys Med Rehabil 98:2181–2187

    Article  PubMed  Google Scholar 

  • Wallace ER, Segerstrom SC, van Horne CG, Schmitt FA, Koehl LM (2022) Meta-analysis of cognition in Parkinson’s disease mild cognitive impairment and dementia progression. Neuropsychol Rev 32:149–160

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors are thankful to patients and their caregivers. Roberta Ferrucci was supported from the Ravelli Research Center (CRC) for Neurotechnology and Brain Therapeutics.

Funding

This research was funded by the Italian Ministry of Health to IRCCS Istituto Auxologico Italiano (Ricerca Corrente, project 23C923) and partially supported by the Italian Ministry of Health to Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico.

Author information

Author notes

  1. Edoardo Nicolò Aiello and Alfonsina D’Iorio have contributed equally to this work; Andrea Ciammola and Barbara Poletti have contributed equally as well.

Authors and Affiliations

  1. Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milan, MI, Italy

    Edoardo Nicolò Aiello, Federica Solca, Silvia Torre, Eleonora Colombo, Alessio Maranzano, Luca Maderna, Claudia Morelli, Alberto Doretti, Federico Verde, Vincenzo Silani, Nicola Ticozzi, Andrea Ciammola & Barbara Poletti

  2. Department of Psychology, University of Campania “Luigi Vanvitelli”, Caserta, Italy

    Alfonsina D’Iorio & Gabriella Santangelo

  3. Neurology Residency Program, Università Degli Studi Di Milano, Milan, Italy

    Ruggero Bonetti & Francesco Scheveger

  4. Institute of Diagnosis and Health, IDC-Hermitage Capodimonte, Naples, Italy

    Marianna Amboni & Carmine Vitale

  5. Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy

    Marianna Amboni

  6. Department of Motor Sciences and Wellness, University “Parthenope”, Naples, Italy

    Carmine Vitale

  7. Department of Pathophysiology and Transplantation, “Dino Ferrari Center”, Università Degli Studi Di Milano, Milan, Italy

    Federico Verde, Vincenzo Silani & Nicola Ticozzi

  8. Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy

    Roberta Ferrucci & Gabriella Pravettoni

  9. Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

    Roberta Ferrucci, Sergio Barbieri & Eleonora Zirone

  10. ASST Santi Paolo e Carlo, San Paolo University Hospital, Milan, Italy

    Alberto Priori

  11. Department of Health Sciences, “Aldo Ravelli” Center for Neurotechnology and Experimental Brain Therapeutics, University of Milan, Milan, Italy

    Alberto Priori

  12. Applied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology, IRCCS, Milan, Italy

    Gabriella Pravettoni

Authors
  1. Edoardo Nicolò Aiello
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alfonsina D’Iorio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Federica Solca
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Silvia Torre
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ruggero Bonetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Francesco Scheveger
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Eleonora Colombo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Alessio Maranzano
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Luca Maderna
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Claudia Morelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Alberto Doretti
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Marianna Amboni
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Carmine Vitale
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Federico Verde
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Roberta Ferrucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Sergio Barbieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Eleonora Zirone
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Alberto Priori
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Gabriella Pravettoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Gabriella Santangelo
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Vincenzo Silani
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. Nicola Ticozzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. Andrea Ciammola
    View author publications

    You can also search for this author in PubMed Google Scholar

  24. Barbara Poletti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Barbara Poletti.

Ethics declarations

Conflict of interest

V. S. received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l., Novartis Pharma AG and Zambon, receives or has received research supports from the Italian Ministry of Health, AriSLA, and E-Rare Joint Transnational Call. He is in the Editorial Board of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, European Neurology, American Journal of Neurodegenerative Diseases, Frontiers in Neurology and Exploration of Neuroprotective Therapy. B.P. received compensation for consulting services and/or speaking activities from Liquidweb S.r.l B.P is Associated Editor for Frontiers in Neuroscience. N. T. received compensation for consulting services from Amylyx Pharmaceuticals and Zambon Biotech SA. He is Associate Editor for Frontiers in Aging Neuroscience.

Ethical approval

This study was approved by the Ethics Committees of IRCCS Istituto Auxologico Italiano (I.D.: 23C923_2019) and University of Campania “Luigi Vanvitelli”.

Informed consent

Participants provided informed consent.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (XLSX 10 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aiello, E.N., D’Iorio, A., Solca, F. et al. Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson’s disease patients. J Neural Transm 130, 687–696 (2023). https://doi.org/10.1007/s00702-023-02624-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-023-02624-7

Keywords

Search

Navigation